 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C31H27N3O5 |
| Molar mass | 521.573 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Nalorphine dinicotinate (trade nameNimelan), also known asN-allylnormorphine dinicotinate,dinicotinoylnalorphine, orniconalorphine, is asemisynthetic, mixedopioidagonist-antagonist which is described as anarcotic antagonist but may produce limited analgesia and sedation at higher doses in opioid naive patients (with limited euphoria and dependence liability).[1][2] It is the 3,6-dinicotinateester ofnalorphine, and is therefore the nalorphineanalogue ofnicomorphine (which is the 3,6-dinicotinate ester ofmorphine).
As nalorphine dinicotinate is only regulated at the Rx (prescription required) drug, it would be legal to possess with a valid prescription should a patient manage to acquire it.[citation needed]
 | Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |
